Pictet Asset Management (UK)’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$12.8M Sell
35,721
-1,079
-3% -$357K 0.01% 630
2021
Q1
$10.4M Sell
36,800
-1,900
-5% -$544K 0.01% 649
2020
Q4
$11M Buy
38,700
+2,500
+7% +$702K 0.01% 607
2020
Q3
$9.95M Sell
36,200
-2,000
-5% -$529K 0.02% 560
2020
Q2
$8.68M Buy
38,200
+10,400
+37% +$2.04M 0.01% 549
2020
Q1
$4.23M Buy
27,800
+2,500
+10% +$385K 0.01% 691
2019
Q4
$3.8M Buy
+25,300
New +$3.68M 0.01% 819

Other funds holding WST

Pictet Asset Management (UK)'s WST Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its West Pharmaceutical (WST) stake by 2.9% in Q2 2021, selling an estimated $357K and leaving 35,721 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #630.

Pictet Asset Management (UK) first reported a position in WST in Q4 2019 and has held it in 7 quarters since. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Pictet Asset Management (UK) held 35,721 shares of West Pharmaceutical worth $12.8M as of Q2 2021.
  • Pictet Asset Management (UK) sold 1,079 West Pharmaceutical shares in Q2 2021, an estimated $357K.
  • West Pharmaceutical made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #630 holding.
  • Pictet Asset Management (UK) first reported a position in West Pharmaceutical in Q4 2019 and has held it in 7 quarters since.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.